A layer-by-layer mass spectrometry intensity method for de novo direct sequencing of RNA therapeutics and impurities
3D NGMS-Seq is a mass spectrometry-based technology that accurately sequences all RNA types and impurities in mixed samples, enabling comprehensive analysis of RNA therapeutics for drug development, quality control, and regulatory compliance.
Background:
The field of RNA-based therapeutics has experienced rapid growth due to the success of mRNA vaccines...
Published: 5/5/2026
|
Inventor(s): Shenglong Zhang
Keywords(s): Mass spectrometry imaging, Technologies
Category(s): Campus > University at Albany, Technology Classifications > Bioinformatics, Technology Classifications > Therapeutics and Vaccines
|